Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer

Over 80% of triple negative breast cancers express mutant p53. Mutant p53 often gains oncogenic function suggesting that triple negative breast cancers may be driven by p53 protein type. To determine the chromatin targets of this gain-of-function mutant p53 we used inducible knockdown of endogenous...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Breast Cancer
Main Authors: Qiu, Wei-Gang, Polotskaia, Alla, Xiao, Gu, Di, Lia, Zhao, Yuhan, Hu, Wenwei, Philip, John, Hendrickson, Ronald C., Bargonetti, Jill
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5319483/
https://ncbi.nlm.nih.gov/pubmed/28232952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-016-0001-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados